Groundbreaking Seed Financing for Cordance Medical
Cordance Medical, a leader in noninvasive focused ultrasound technology for treating brain diseases, has successfully completed an oversubscribed seed financing round. This milestone was highlighted by exceeding the initial $8 million target, with participation from both new and existing investors such as Shanda Grab Ventures and Angel Physician's Fund.
Investors Highlight the Promise of the Platform
Alongside Cordance Medical, notable supporters in this financing round included the Sontag Foundation Innovation Fund and the Brain Tumor Investment Fund. Their involvement underscores the anticipated positive impact of the focused ultrasound technology on neuro-oncology care. This financial boost is expected to facilitate more advanced research into brain disease treatments, potentially revolutionizing patient outcomes.
Transformative Clinical Trials Ahead
The raised funds will be allocated toward the company's inaugural clinical trial involving human patients. This trial aims to demonstrate the effectiveness of a focused ultrasound platform designed to safely and temporarily open the blood-brain barrier (BBB). This innovation is crucial as it may significantly enhance the efficacy of delivering therapeutic agents to target brain conditions, including cancer and other neurological diseases.
Innovative Technology for Patient-Centric Care
Cordance Medical's technology stands out in its ability to provide outpatient treatment that is both scalable and patient-friendly. The platform uniquely offers patient-specific signal processing and real-time monitoring of the BBB opening. This process occurs without necessitating head fixation or intricate imaging during treatment sessions, making it a more accessible option for patients.
Support from Leading Organizations
In addition to the funding, Cordance Medical received an FDA Breakthrough Device Designation tailored for neuro-oncology applications. Furthermore, the National Cancer Institute has awarded them a grant to support the critical U.S. clinical trial. These recognitions strengthen the credibility and viability of their research efforts.
CEO Bhaskar Ramamurthy on Future Plans
Bhaskar Ramamurthy, PhD, Co-founder and CEO, expressed excitement regarding this funding achievement. He emphasized gratitude to investors, partners, and collaborators who endorse their vision to create precision therapies in neurology. The backing from NIH for their trial signifies a significant step towards delivering life-altering treatments for patients with limited options.
Revolutionizing Neurology Treatments
Deborah Kilpatrick, PhD, a Partner at Sonder Capital, noted the transformative nature of focused ultrasound technology across various therapeutic domains. She believes that Cordance Medical is well-positioned to set new standards in neurology. This technology's outpatient delivery approach caters to both pediatric and adult patients, enhancing the accessibility of cutting-edge treatments.
About Cordance Medical
Cordance Medical is innovating a noninvasive focused ultrasound platform poised to safely and temporarily open the blood-brain barrier. This advancement is vital for developing new therapeutic strategies for brain cancer and other neurological ailments. Based out of Mountain View, California, Cordance Medical has garnered support from key healthcare investors dedicated to improving neurology care.
Contact Information
For further information, media inquiries can be directed to Alexander Jonsson at +1 (650) 241-8275.
Frequently Asked Questions
What is Cordance Medical known for?
Cordance Medical is recognized for its development of focused ultrasound technology specifically designed for brain disease treatment.
How much funding did Cordance Medical raise?
The company raised an oversubscribed funding round exceeding its initial target of $8 million.
What is the purpose of the new funding?
The funding will support the first clinical trial of their ultrasound platform aimed at opening the blood-brain barrier.
What makes Cordance's technology unique?
The technology enables noninvasive BBB opening, enhancing drug delivery to the brain without complex procedures.
Where is Cordance Medical located?
Cordance Medical operates out of Mountain View, California, focusing on advancing neurological care.
